Belgium· BE-AMP-SAM664026-00

Alitretinoin Orifarm 30 mg

A alitretinoin product containing alitretinoin, registered in Belgium by Orifarm Generics. The same ATC class is registered in 8 of our 19 countries.

ATC D11AH04

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about alitretinoinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Alitretinoin is registered in 8 of 19 countries.

Countries holding a registration under ATC D11AH04 (alitretinoin), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
5 of them publish a price we can compare per daily dose

Search alitretinoin products by name

Alitretinoin · ATC D11AH04

8 / 19 countries

Belgiumprice
Canada
Denmark
Finlandprice
Netherlands
Norwayprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alitretinoin costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Alitretinoin · price per daily dose (20 mg)

USD · FX 28 Sept 2026

CH Switzerland$17.29

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Alitretinoin
Manufacturer: Orifarm Generics
Country: Belgium (BE)
ATC code: D11AH04
ATC class: Alitretinoin
Defined daily dose: 20 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

1 priced

be_apb
7748148
be_apb
5812607
EUR 238.86

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for alitretinoin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check alitretinoin against other medicines How interaction checks work

Alitretinoin · interactions on record

5 records

1 severe
4 moderate

Most severe, free to view

Aminolevulinic acidL01XD04severe
Salicylic acidD01AE12moderate
Porfimer sodiumL01XD01moderate
MethoxsalenL01XD10moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alitretinoin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alitretinoin products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

Austria · Alitretan, Toctino
Germany · Alitrederm, Toctino
Denmark · Alitretinoin Orifarm, Toctino
Spain · Alitretinoína Ifc, Toctino
Finland · Alitretinoin Orifarm, Toctino
France · Alizem, Toctino
United Kingdom (Northern Ireland) · Alitretinoin Ennogen Healthcare, Alitretinoin Ennogen Ip
Italy · Alitrecare, Toctino
Netherlands · Alipalmtin, Alitretinoïne Ifc
Norway · Alitretinoin Orifarm, Toctino
Portugal · Alitretinoína Cantabria
Sweden · Alitretinoin Orifarm
Slovenia · Toctino

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f817b9b5-a17d-4dc9-8bbb-9a7d6f802105
GET /v1/drugs/f817b9b5-a17d-4dc9-8bbb-9a7d6f802105?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, soft",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Alitretinoin Orifarm  30 mg",
  "name_fr": "Alitretinoin Orifarm  30 mg",
  "name_nl": "Alitretinoin Orifarm  30 mg",
  "amp_code": "SAM664026-00",
  "strengths": [
    "30.0000",
    "30.0000",
    "27.9820",
    "17.3880",
    "261.4440",
    "25.5480",
    "7.7890"
  ],
  "pack_count": 1,
  "substances": [
    "Alitretinoin",
    "Glycerol",
    "Glycine max - Glycine soja (Ph.Eur. mixture), Bean, Oil - Hydrogenated (partially)",
    "Glycine max - Glycine soja (Ph.Eur. mixture), Bean, Oil - Refined",
    "Sorbitol Liquid Non-Crystallising",
    "Vegetable Oil, Hydrogenated"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Alitretinoin",
  "authorisation_numbers": [
    "BE664026"
  ]
}

API reference MCP server Plans

See everything about alitretinoin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console